Lukas Schulig

430 total citations
33 papers, 329 citations indexed

About

Lukas Schulig is a scholar working on Molecular Biology, Organic Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, Lukas Schulig has authored 33 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 7 papers in Organic Chemistry and 5 papers in Computational Theory and Mathematics. Recurrent topics in Lukas Schulig's work include Computational Drug Discovery Methods (5 papers), Ion channel regulation and function (5 papers) and Analytical Chemistry and Chromatography (3 papers). Lukas Schulig is often cited by papers focused on Computational Drug Discovery Methods (5 papers), Ion channel regulation and function (5 papers) and Analytical Chemistry and Chromatography (3 papers). Lukas Schulig collaborates with scholars based in Germany, Poland and United States. Lukas Schulig's co-authors include Andreas Link, Abdrrahman Shemsu Surur, Patrick J. Bednarski, Anja Bodtke, Markus Kindermann, Walter Langel, R. Hofstetter, Martin Kulke, Werner Siegmund and Simon Kim and has published in prestigious journals such as The Journal of Physical Chemistry B, ACS Catalysis and Journal of Cell Science.

In The Last Decade

Lukas Schulig

30 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lukas Schulig Germany 11 132 104 36 34 32 33 329
İsmail Erol Türkiye 12 140 1.1× 55 0.5× 24 0.7× 44 1.3× 30 0.9× 28 337
John P. Caldwell United States 13 186 1.4× 173 1.7× 17 0.5× 47 1.4× 24 0.8× 22 392
Marta Barniol‐Xicota Spain 15 246 1.9× 153 1.5× 26 0.7× 15 0.4× 27 0.8× 28 500
Peter Söderman Sweden 11 194 1.5× 140 1.3× 20 0.6× 12 0.4× 42 1.3× 19 468
Anas Najjar Palestinian Territory 8 146 1.1× 78 0.8× 30 0.8× 30 0.9× 8 0.3× 11 452
Carmine Varricchio United Kingdom 14 156 1.2× 148 1.4× 14 0.4× 28 0.8× 7 0.2× 25 464
Zeynep Şafak Teksin Türkiye 11 121 0.9× 30 0.3× 27 0.8× 36 1.1× 42 1.3× 23 409
Dong-Jin Jang South Korea 14 116 0.9× 44 0.4× 79 2.2× 9 0.3× 56 1.8× 40 549
Akansha Saxena United States 10 231 1.8× 23 0.2× 20 0.6× 66 1.9× 24 0.8× 15 368
Prasanna Raju Yalavarthi India 12 76 0.6× 52 0.5× 28 0.8× 12 0.4× 12 0.4× 28 343

Countries citing papers authored by Lukas Schulig

Since Specialization
Citations

This map shows the geographic impact of Lukas Schulig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lukas Schulig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lukas Schulig more than expected).

Fields of papers citing papers by Lukas Schulig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lukas Schulig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lukas Schulig. The network helps show where Lukas Schulig may publish in the future.

Co-authorship network of co-authors of Lukas Schulig

This figure shows the co-authorship network connecting the top 25 collaborators of Lukas Schulig. A scholar is included among the top collaborators of Lukas Schulig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lukas Schulig. Lukas Schulig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weigmann, Katrin, Bas Vroling, Nathalie Michels, et al.. (2025). Navigating the Sequence-Function Landscape: AI-Driven Discovery of Unseen and Synergistic Mutations in an Amine Transaminase. ACS Catalysis. 15(17). 15121–15131. 1 indexed citations
2.
Grabarczyk, Piotr, et al.. (2025). Double the Double: Revisiting BCL11B's Multimerization. Proteins Structure Function and Bioinformatics. 93(7). 1205–1211.
3.
Schulig, Lukas, et al.. (2025). Lead Optimization of Positive Allosteric KV7.2/3 Channel Modulators toward Improved Balance of Lipophilicity and Aqueous Solubility. Journal of Medicinal Chemistry. 68(8). 8377–8399. 1 indexed citations
4.
Schöne, Tilo, et al.. (2024). Structure‐activity‐relationships of the Stability of Six Pentathiepins Towards Glutathione: Possible Correlations with Biological Activities. ChemMedChem. 20(5). e202400727–e202400727. 1 indexed citations
5.
Schulig, Lukas, Georg Manolikakes, Dennis Schade, et al.. (2024). Targeting PARP-1 and DNA Damage Response Defects in Colorectal Cancer Chemotherapy with Established and Novel PARP Inhibitors. Cancers. 16(20). 3441–3441. 2 indexed citations
6.
Gollasch, Maik, et al.. (2024). Advances in the design and development of chemical modulators of the voltage-gated potassium channels K V 7.4 and K V 7.5. Expert Opinion on Drug Discovery. 20(1). 47–62. 3 indexed citations
7.
Surur, Abdrrahman Shemsu, Iris L. K. Wong, Lukas Schulig, et al.. (2024). Fexinidazole optimization: enhancing anti-leishmanial profile, metabolic stability and hERG safety. RSC Medicinal Chemistry. 15(11). 3837–3852.
8.
Malecki, P.H., Lukas Schulig, Andreas Link, et al.. (2024). Structure-based mapping of the histone-binding pocket of KDM4D using functionalized tetrazole and pyridine core compounds. European Journal of Medicinal Chemistry. 276. 116642–116642.
9.
Link, Andreas, et al.. (2023). Advances in the discovery of new chemotypes through ultra-large library docking. Expert Opinion on Drug Discovery. 18(3). 303–313. 16 indexed citations
11.
Schulig, Lukas, et al.. (2022). Carba Analogues of Flupirtine and Retigabine with Improved Oxidation Resistance and Reduced Risk of Quinoid Metabolite Formation. ChemMedChem. 17(16). e202200262–e202200262. 12 indexed citations
12.
Eger, Elias, Michael Schwabe, Lukas Schulig, et al.. (2022). Extensively Drug-Resistant Klebsiella pneumoniae Counteracts Fitness and Virulence Costs That Accompanied Ceftazidime-Avibactam Resistance Acquisition. Microbiology Spectrum. 10(3). e0014822–e0014822. 27 indexed citations
13.
Kulke, Martin, Lukas Schulig, Julia Mayerle, et al.. (2021). A Hypothesized Mechanism for Chronic Pancreatitis Caused by the N34S Mutation of Serine Protease Inhibitor Kazal-Type 1 Based on Conformational Studies. Journal of Inflammation Research. Volume 14. 2111–2119. 4 indexed citations
14.
Kohler, Thomas P., et al.. (2021). Pneumococcal Extracellular Serine Proteases: Molecular Analysis and Impact on Colonization and Disease. Frontiers in Cellular and Infection Microbiology. 11. 763152–763152. 10 indexed citations
15.
Schulig, Lukas, Piotr Grabarczyk, Martin Kulke, et al.. (2021). Unveiling the N-Terminal Homodimerization of BCL11B by Hybrid Solvent Replica-Exchange Simulations. International Journal of Molecular Sciences. 22(7). 3650–3650. 3 indexed citations
17.
Surur, Abdrrahman Shemsu, Lukas Schulig, Markus Kindermann, et al.. (2019). Flupirtine and retigabine as templates for ligand-based drug design of KV7.2/3 activators. Organic & Biomolecular Chemistry. 17(18). 4512–4522. 23 indexed citations
19.
Kulke, Martin, et al.. (2019). Replica-Based Protein Structure Sampling Methods II: Advanced Hybrid Solvent TIGER2hs. The Journal of Physical Chemistry B. 123(28). 5995–6006. 14 indexed citations
20.
Surur, Abdrrahman Shemsu, et al.. (2018). Synthesis and potassium KV7 channel opening activity of thioether analogues of the analgesic flupirtine. Organic & Biomolecular Chemistry. 16(45). 8695–8699. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026